# Study of Gemcitabine Maintenance Treatment in Patients With Extensive SCLC Patients

> **NCT02039518** · PHASE2 · UNKNOWN · sponsor: **Fudan University** · enrollment: 160 (estimated)

## Conditions studied

- Small Cell Lung Cancer

## Interventions

- **DRUG:** gemcitabine
- **OTHER:** observation group

## Key facts

- **NCT ID:** NCT02039518
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-12
- **Primary completion:** 2017-06
- **Final completion:** 2017-06
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2014-01-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02039518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02039518, "Study of Gemcitabine Maintenance Treatment in Patients With Extensive SCLC Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02039518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*